View Section: Company Analysis
Santhera Pharmaceuticals Rating
S3
S3F.F stock rating score is 109/100. Santhera Pharmaceuticals is aViable Investment.
The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.
Eyestock Rating
Last update 23.09.2024
109/100
High score
Rating Breakdown
Profitability score
32
/25
Solvency score
27
/25
Efficiency score
50
/25
Stability score
0
/25
Santhera Pharmaceuticals Holding AG Rewards and Warnings
The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.
Financial
Check
Value
Net Profit Margin
55 %
Earnings quality
75 %
Gross Margin
94 %
Santhera Pharmaceuticals Holding AG's Historical Rating
How has the company's valuation changed in the past?
A quick analysis will help you understand how stable financial indicators are overall.
Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Discover High-rated Companies
View Section: Valuation